CLINICAL_TRIALS
trial_result
· 2023-06-12
Clinical Trial Update: Efficacy and Safety of Telitacicept in Early SLE [Phase 4]
Summary
Phase 4 clinical trial update evaluating telitacicept for systemic lupus erythematosus, focusing on efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking Union Medical College Hospital | Conditions: Lupus Erythematosus, Systemic | Phase 4 | Status: UNKNOWN